Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Outcomes4Me has acquired Geno.Me and Realyze Intelligence to strengthen its AI platform for cancer care and clinical trial matching. The company also appointed UPMC Hillman Cancer Center CIO Scot Stevens as Strategic Advisor.
MGI Tech unveiled new automation and multi omics solutions at SLAS 2026 in Vienna, including systems for single cell proteomics, clinical sample processing, and spatial proteomics imaging.
RADIN Health and AZmed have expanded their partnership following FDA clearance of AZtrauma, now covering fractures, joint effusions, and dislocations in both adults and children. The AI module integrates with RADIN’s platform to enhance radiology workflow and reporting efficiency.
Vu Technologies has partnered with Moffitt Cancer Center to deploy a 3D microscopy visualizer powered by NVIDIA DGX Spark, enabling faster, AI-driven tumor imaging for biomedical research.
Hyro has partnered with Five9 to integrate healthcare-specific AI agents into the Five9 Intelligent Cloud Contact Center, reducing integration time for health systems to as little as one hour.
Bristol Myers Squibb has entered a strategic agreement with Anthropic to deploy Claude Enterprise across its global operations, integrating AI agents into research, development, manufacturing, and commercial workflows for over 30,000 employees.
MemorialCare has implemented Cleerly’s FDA-cleared AI coronary analysis technology across its hospitals, making Long Beach Medical Center the first in Los Angeles County to offer AI-based plaque quantification for heart disease assessment.
IGEL and Zscaler have introduced new healthcare security blueprints to help organizations secure distributed care delivery environments. The guidance, presented at HIMSS26 Europe, combines IGEL's endpoint platform with Zscaler's Zero Trust Exchange to protect clinical systems and patient data.
Araceli Biosciences has introduced Endeavor Live Cell, an imaging system designed to enable rapid kinetic imaging for large-scale screening in AI-driven drug discovery workflows.
Flywheel announced an integration with AWS HealthImaging to streamline the management of medical imaging data for clinical trials, research, and AI development. The collaboration enables organizations to create standardized, analysis-ready imaging datasets across regulated and exploratory workflows.
NeuroDiscovery AI has introduced NeuroTerminal, a platform built for neurology research that integrates clinical trial management, real world data, and medical affairs to speed up patient recruitment and therapy access.
Biotia has introduced BIOTIA-DX Resistance, an antimicrobial resistance profiling tool now integrated into its CLEP-approved BIOTIA-ID Urine Test for clinical use across the U.S. The platform provides rapid resistance prediction to guide treatment for complicated urinary tract infections.
Open Medicine has launched a new platform called Living Algorithms, designed to help clinicians make faster and more informed cancer treatment decisions by sharing continuously updated, interactive treatment pathways authored by leading physicians.
A new report from 5WPR shows that Novo Nordisk and Eli Lilly account for nearly all GLP-1 citations across AI platforms like ChatGPT, Claude, and Perplexity, with their brands controlling 57% of total mentions in the weight loss category.
Sino Biological has launched the XPressMAX Cell Free Protein Synthesis Kit, enabling protein and antibody synthesis in three hours to support AI driven high throughput screening for antibody drug discovery.
28bio has launched CNS-3D Inflammatory Organoids, a human brain tissue model designed to test the efficacy of anti-inflammatory drugs in central nervous system diseases. The organoids combine neurons, astrocytes, and microglia to simulate inflammation and assess therapeutic responses.
Genedata has introduced Genedata Vico, an AI based platform developed with major pharmaceutical partners to accelerate Chemistry, Manufacturing, and Controls (CMC) processes and improve regulatory readiness.
Verato has announced the Verato Identity Network, a shared identity infrastructure designed to help healthcare organizations accurately identify individuals across systems and partners, enabling AI adoption and interoperability.
A large-scale study from GlycanAge and Circulate Health has confirmed IgG glycans as predictive of all-cause mortality and responsive to therapeutic plasma exchange, marking a significant advance in biological age measurement.
Azra AI has appointed oncology strategist Jessica Turgon to its Board of Directors. Turgon brings decades of experience in oncology operations and strategy, including leadership roles at Siemens Healthineers and ECG Management Consultants.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
